IBDEI22R ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,34787,1,3,0)
 ;;=3^ZOLADEX 3.6MG
 ;;^UTILITY(U,$J,358.3,34788,0)
 ;;=J0885^^162^1771^14^^^^1
 ;;^UTILITY(U,$J,358.3,34788,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,34788,1,2,0)
 ;;=2^J0885
 ;;^UTILITY(U,$J,358.3,34788,1,3,0)
 ;;=3^EPOGEN INJ, NON-ESRD 1000 UNITS
 ;;^UTILITY(U,$J,358.3,34789,0)
 ;;=J0881^^162^1771^4^^^^1
 ;;^UTILITY(U,$J,358.3,34789,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,34789,1,2,0)
 ;;=2^J0881
 ;;^UTILITY(U,$J,358.3,34789,1,3,0)
 ;;=3^ARANESP (NON-ESRD) 1MCG
 ;;^UTILITY(U,$J,358.3,34790,0)
 ;;=J0882^^162^1771^3^^^^1
 ;;^UTILITY(U,$J,358.3,34790,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,34790,1,2,0)
 ;;=2^J0882
 ;;^UTILITY(U,$J,358.3,34790,1,3,0)
 ;;=3^ARANESP (ESRD) 1MCG
 ;;^UTILITY(U,$J,358.3,34791,0)
 ;;=J1826^^162^1771^27^^^^1
 ;;^UTILITY(U,$J,358.3,34791,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,34791,1,2,0)
 ;;=2^J1826
 ;;^UTILITY(U,$J,358.3,34791,1,3,0)
 ;;=3^INTERFERON BETA-1A 30mcg
 ;;^UTILITY(U,$J,358.3,34792,0)
 ;;=J9217^^162^1771^35^^^^1
 ;;^UTILITY(U,$J,358.3,34792,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,34792,1,2,0)
 ;;=2^J9217
 ;;^UTILITY(U,$J,358.3,34792,1,3,0)
 ;;=3^LEUPROLIDE INJ 7.5MG
 ;;^UTILITY(U,$J,358.3,34793,0)
 ;;=J9218^^162^1771^33^^^^1
 ;;^UTILITY(U,$J,358.3,34793,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,34793,1,2,0)
 ;;=2^J9218
 ;;^UTILITY(U,$J,358.3,34793,1,3,0)
 ;;=3^LEUPROLIDE INJ 1MG
 ;;^UTILITY(U,$J,358.3,34794,0)
 ;;=J1950^^162^1771^34^^^^1
 ;;^UTILITY(U,$J,358.3,34794,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,34794,1,2,0)
 ;;=2^J1950
 ;;^UTILITY(U,$J,358.3,34794,1,3,0)
 ;;=3^LEUPROLIDE INJ 3.75MG
 ;;^UTILITY(U,$J,358.3,34795,0)
 ;;=J9219^^162^1771^32^^^^1
 ;;^UTILITY(U,$J,358.3,34795,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,34795,1,2,0)
 ;;=2^J9219
 ;;^UTILITY(U,$J,358.3,34795,1,3,0)
 ;;=3^LEUPROLIDE IMPLANT 65MG
 ;;^UTILITY(U,$J,358.3,34796,0)
 ;;=J0696^^162^1771^60^^^^1
 ;;^UTILITY(U,$J,358.3,34796,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,34796,1,2,0)
 ;;=2^J0696
 ;;^UTILITY(U,$J,358.3,34796,1,3,0)
 ;;=3^ROCEPHIN INJ-250MG
 ;;^UTILITY(U,$J,358.3,34797,0)
 ;;=J0696^^162^1771^59^^^^4
 ;;^UTILITY(U,$J,358.3,34797,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,34797,1,2,0)
 ;;=2^J0696
 ;;^UTILITY(U,$J,358.3,34797,1,3,0)
 ;;=3^ROCEPHIN INJ-1GM
 ;;^UTILITY(U,$J,358.3,34798,0)
 ;;=J1030^^162^1771^39^^^^1
 ;;^UTILITY(U,$J,358.3,34798,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,34798,1,2,0)
 ;;=2^J1030
 ;;^UTILITY(U,$J,358.3,34798,1,3,0)
 ;;=3^METHYLPREDNISOLONE INJ 40MG
 ;;^UTILITY(U,$J,358.3,34799,0)
 ;;=J1020^^162^1771^38^^^^1
 ;;^UTILITY(U,$J,358.3,34799,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,34799,1,2,0)
 ;;=2^J1020
 ;;^UTILITY(U,$J,358.3,34799,1,3,0)
 ;;=3^METHYLPREDNISOLONE INJ 20MG
 ;;^UTILITY(U,$J,358.3,34800,0)
 ;;=J1040^^162^1771^40^^^^1
 ;;^UTILITY(U,$J,358.3,34800,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,34800,1,2,0)
 ;;=2^J1040
 ;;^UTILITY(U,$J,358.3,34800,1,3,0)
 ;;=3^METHYLPREDNISOLONE INJ 80MG
 ;;^UTILITY(U,$J,358.3,34801,0)
 ;;=J2920^^162^1771^42^^^^1
 ;;^UTILITY(U,$J,358.3,34801,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,34801,1,2,0)
 ;;=2^J2920
 ;;^UTILITY(U,$J,358.3,34801,1,3,0)
 ;;=3^METHYLPREDNISOLONE SOD IV 40MG
 ;;^UTILITY(U,$J,358.3,34802,0)
 ;;=J2930^^162^1771^41^^^^1
 ;;^UTILITY(U,$J,358.3,34802,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,34802,1,2,0)
 ;;=2^J2930
 ;;^UTILITY(U,$J,358.3,34802,1,3,0)
 ;;=3^METHYLPREDNISOLONE SOD IV 125MG
 ;;^UTILITY(U,$J,358.3,34803,0)
 ;;=J1756^^162^1771^29^^^^1
 ;;^UTILITY(U,$J,358.3,34803,1,0)
 ;;=^358.31IA^3^2
